Recent Updates
Recently added Catalysts
NTLA Positive Sentiment

Intellia Therapeutics to Hold Conference Call to Discuss Fourth Quarter and Full-Year 2022 Earnings and Company Updates

Thursday, February 16, 2023 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Intellia Therapeutics, a clinical-stage genome editing firm, will host a conference call on February 23, 2023, to discuss its fourth-quarter and full-year 2022 financial results alongside operational updates. The call is set for 8 a.m. ET, with details on connecting provided for U.S. and international callers. A replay of the call will be accessible later on the company's website.
Price reaction · baseline $41.78 (2023-02-15 close) · hit after-hours · clean, no other NTLA news in the window
day 0 close · peak
-4.7%

Market Sentiment Analysis

POSITIVE FACTORS

  • Intellia Therapeutics is showcasing its financial results and operational highlights.
  • The company is positioned in the cutting-edge field of genome editing.
  • The upcoming conference call presents an opportunity for investor engagement.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+76%
120-day peak, hindsight
Typical move
9.6%
average across 8 past catalysts
Cash runway
~22 mo
Low dilution risk
Lead asset
NTLA-2002
Phase 3 · Hereditary Angioedema

Full Press Release Details

CAMBRIDGE, Mass., Feb. 16, 2023 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage genome editing company focused on developing potentially curative therapeutics leveraging CRISPR-based technologies, will present its fourth quarter and full-year 2022 financial results and operational highlights in a conference call on February 23, 2023, at 8 a.m. ET.
U.S. callers should dial 1-833-316-0545 and international callers should dial 1-412-317-5726, approximately five minutes before the call. All participants should ask to be connected to the Intellia Therapeutics conference call.
Please visit this link for a simultaneous live webcast of the call.
A replay of the call will be available through the Events and Presentations page of the Investors & Media section on Intellia’s website at www.intelliatx.com, beginning on February 23, 2023, at 12 p.m. ET.
About Intellia Therapeutics

Frequently Asked Questions

When will Intellia Therapeutics present its financial results?

Intellia Therapeutics will present its financial results on February 23, 2023.

What time is the Intellia conference call scheduled?

The conference call is scheduled for 8 a.m. ET on February 23, 2023.

How can I join the Intellia conference call?

U.S. callers can dial 1-833-316-0545 and international callers 1-412-317-5726.

Where can I find the replay of the conference call?

The replay will be available on Intellia’s Events and Presentations page.

Who should I contact for investor relations at Intellia?

Contact Ian Karp at ian.karp@intelliatx.com for investor relations inquiries.

ShareAdd on Google
Tags: NTLA Viatris Investor Conferences Healthcare Intellia Therapeutics genome editing financial results February earnings call
Last updated: Feb 16, 2023

Biotech snapshot

Cash runway
$628M liquidity · $28M/mo burn
~22 mo
Low dilution risk
Lead asset
NTLA-2002Phase 3
Hereditary Angioedema →

Catalyst track record

+76%
best trade around NTLA's most recent catalyst

Peak hindsight return over a 120-day window, across 8 tracked FDA/PDUFA catalysts for NTLA.

See every catalyst's timing & PoA →